Medication-Aware Financial Exploitation Detection for Alzheimer's Patients Using Edge-Aware Interaction Risk Modeling
Financial exploitation is a growing concern for people with Alzheimer's disease, especially during periods of reduced cognitive stability. Conventional fraud detection systems usually rely on financial behavior alone and ignore clinically relevant factors that may alter vulnerability. This paper proposes a medication-aware framework that synchronizes medication adherence with transaction-level monitoring to improve detection of cognitively risky financial events. A hybrid simulation dataset was constructed for 180 patients across 45 days, producing 8,100 medication records and 30,855 transactions. The framework evaluates amount anomaly, vendor novelty, transaction frequency, time deviation, and medication adherence through financial-only, additive medication-aware, and interaction-aware logistic models. Results show that the financial-only baseline obtained the highest global F1-score of 0.5000, but the interaction-aware model improved recall during medication-induced vulnerability windows from 0.7442 to 0.9070 and achieved the highest average precision for ranked high-risk cases. The findings suggest that medication adherence is most useful as a contextual modifier of financial risk rather than as an isolated predictor.
Code (0)
등록된 구현이 없습니다.
Tasks
Fraud DetectionSimilar Papers 제목 키워드 기반
Preclinical Stage Alzheimer's Disease Detection Using Magnetic Resonance Image Scans
Alzheimer's disease is one of the diseases that mostly affects older people without being a part of aging. The most common symptoms include problems with communicating and abstract thinking, as well as disorientation. It…
Alzheimer's Disease DetectionALPACA: A Reinforcement Learning Environment for Medication Repurposing and Treatment Optimization in Alzheimer's Disease
Evaluating personalized, sequential treatment strategies for Alzheimer's disease (AD) using clinical trials is often impractical due to long disease horizons and substantial inter-patient heterogeneity. To address these …
Reinforcement LearningTemporal Subtyping of Alzheimer's Disease Using Medical Conditions Preceding Alzheimer's Disease Onset in Electronic Health Records
Subtyping of Alzheimer's disease (AD) can facilitate diagnosis, treatment, prognosis and disease management. It can also support the testing of new prevention and treatment strategies through clinical trials. In this stu…
ClusteringManagementPrognosisMEMOR-E: In-Context and Fine-Tuned LLM Personalization for Alzheimer's Assistive Robotics
Alzheimer's disease is a neurodegenerative disorder marked by progressive declines in memory and language that reduce independence in daily life, motivating socially assistive robotic support. This paper presents MEMOR-E…
Large language models improve Alzheimer's disease diagnosis using multi-modality data
In diagnosing challenging conditions such as Alzheimer's disease (AD), imaging is an important reference. Non-imaging patient data such as patient information, genetic data, medication information, cognitive and memory t…
Language ModelingLanguage ModellingLarge Language Model